{"entity":{"type":"insider","cik":"0001560152","url":"/insider/0001560152","json_url":"/insider/0001560152.json","name":"Fallon John A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":12,"first":"2015-11-10","last":"2025-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Fallon John A.","source":"filing","n_filings":12,"first_seen":"2015-11-10","last_seen":"2025-11-14"}],"transactions":[{"id":4400837,"accession":"0001560152-25-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001560152-25-000004","line_url":"/filing/0001560152-25-000004#line-3","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34853.0,"shares_display":"34,853","price_per_share":47.2136,"price_display":"47.21","price_state":"stated","total_value":1645535.6008,"total_display":"1,645,535.60","total_whole":"1,645,536","shares_owned_after":64634.0,"shares_owned_after_display":"64,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":5060497,"accession":"0001127602-21-018010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-018010","line_url":"/filing/0001127602-21-018010","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5822.0,"shares_display":"5,822","price_per_share":253.35874742356577,"price_display":"253.36","price_state":"stated","total_value":1475054.6275,"total_display":"1,475,054.63","total_whole":"1,475,055","shares_owned_after":14498.0,"shares_owned_after_display":"14,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-25","scope":"insider","n_lines":2},{"id":2408554,"accession":"0001127602-20-028354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-028354","line_url":"/filing/0001127602-20-028354#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":230.0,"price_display":"230.00","price_state":"stated","total_value":690000.0,"total_display":"690,000.00","total_whole":"690,000","shares_owned_after":14498.0,"shares_owned_after_display":"14,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider"},{"id":2810754,"accession":"0001127602-20-027995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-027995","line_url":"/filing/0001127602-20-027995#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":225.0,"price_display":"225.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","total_whole":"900,000","shares_owned_after":14498.0,"shares_owned_after_display":"14,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":8059482,"accession":"0001127602-19-033198","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-19-033198","line_url":"/filing/0001127602-19-033198#line-5","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9525.0,"shares_display":"9,525","price_per_share":181.4087,"price_display":"181.41","price_state":"stated","total_value":1727917.8675,"total_display":"1,727,917.87","total_whole":"1,727,918","shares_owned_after":13469.0,"shares_owned_after_display":"13,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-19","scope":"insider"},{"id":8059471,"accession":"0001127602-19-033198","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-033198","line_url":"/filing/0001127602-19-033198#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":180.065,"price_display":"180.06","price_state":"stated","total_value":900325.0,"total_display":"900,325.00","total_whole":"900,325","shares_owned_after":13469.0,"shares_owned_after_display":"13,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-19","scope":"insider"},{"id":7896416,"accession":"0001127602-19-012921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-012921","line_url":"/filing/0001127602-19-012921#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":11743.0,"shares_owned_after_display":"11,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-22","scope":"insider"},{"id":8700462,"accession":"0001127602-19-011377","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-011377","line_url":"/filing/0001127602-19-011377#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":95.0,"price_display":"95.00","price_state":"stated","total_value":475000.0,"total_display":"475,000.00","total_whole":"475,000","shares_owned_after":11743.0,"shares_owned_after_display":"11,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":8243779,"accession":"0001127602-19-010579","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-010579","line_url":"/filing/0001127602-19-010579#line-2","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":92.64,"price_display":"92.64","price_state":"stated","total_value":926400.0,"total_display":"926,400.00","total_whole":"926,400","shares_owned_after":11743.0,"shares_owned_after_display":"11,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-06","filed_date":"2019-03-08","scope":"insider"},{"id":6478591,"accession":"0001209191-18-044763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-044763","line_url":"/filing/0001209191-18-044763#line-1","is_derivative":false,"issuer_cik":"0001124140","issuer_name":"EXACT SCIENCES CORP","issuer_ticker":"EXAS","issuer_name_source":null,"issuer_url":"/issuer/0001124140","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2373.0,"shares_display":"2,373","price_per_share":58.86,"price_display":"58.86","price_state":"stated","total_value":139674.78,"total_display":"139,674.78","total_whole":"139,675","shares_owned_after":33767.0,"shares_owned_after_display":"33,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-30","filed_date":"2018-08-01","scope":"insider"},{"id":6294039,"accession":"0001127602-18-011891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-011891","line_url":"/filing/0001127602-18-011891","is_derivative":false,"issuer_cik":"0001145197","issuer_name":"INSULET CORP","issuer_ticker":"PODD","issuer_name_source":null,"issuer_url":"/issuer/0001145197","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":84.10144444444444,"price_display":"84.10","price_state":"stated","total_value":756913.0,"total_display":"756,913.00","total_whole":"756,913","shares_owned_after":9758.0,"shares_owned_after_display":"9,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-16","scope":"insider","n_lines":2},{"id":2694633,"accession":"0001192482-16-000696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-16-000696","line_url":"/filing/0001192482-16-000696#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2375.0,"shares_display":"2,375","price_per_share":10.59,"price_display":"10.59","price_state":"stated","total_value":25151.25,"total_display":"25,151.25","total_whole":"25,151","shares_owned_after":2375.0,"shares_owned_after_display":"2,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-12","filed_date":"2016-08-15","scope":"insider"},{"id":8235702,"accession":"0001179110-15-014704","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-014704","line_url":"/filing/0001179110-15-014704#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001560152","owner_name":"Fallon John A.","owner_display_name":"Fallon John A.","owner_url":"/insider/0001560152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3230.0,"shares_display":"3,230","price_per_share":31.2,"price_display":"31.20","price_state":"stated","total_value":100776.0,"total_display":"100,776.00","total_whole":"100,776","shares_owned_after":6086.0,"shares_owned_after_display":"6,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-10","filed_date":"2015-11-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Director","n_filings":2,"first_seen":"2016-08-15","last_seen":"2025-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001145197","name":"INSULET CORP","url":"/issuer/0001145197","role":"Director","n_filings":8,"first_seen":"2018-03-16","last_seen":"2021-05-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001124140","name":"EXACT SCIENCES CORP","url":"/issuer/0001124140","role":"Director","n_filings":1,"first_seen":"2018-08-01","last_seen":"2018-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000792977","name":"AMAG PHARMACEUTICALS INC.","url":"/issuer/0000792977","role":"Director","n_filings":1,"first_seen":"2015-11-10","last_seen":"2015-11-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001560152","retrieved_at":"2026-08-24T15:27:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}